Navigation Links
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference
Date:12/5/2013

at the Morgan Stanley Conference; or the Company will be successful in obtaining FDA approval for its product candidates. While the Company may elect to update the forward-looking statements made in this news release in the future, the Company specifically disclaims any obligation to do so. Such forward-looking statements are subject to a wide range of risks and uncertainties that could cause results to differ in material respects, including those relating to product development, revenue, expense and earnings expectations, intellectual property rights, results and timing of clinical trials, success of marketing efforts, the need for additional research and testing, and the timing and content of decisions made by regulatory authorities, including the U.S. Food and Drug Administration, and those risks discussed in our reports on file with the Securities and Exchange Commission (the "SEC"). Our SEC filings may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "For Investors - SEC Filings." There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements.
Auxilium Contacts:Keri P. Mattox / SVP, IR &Nichol L. Ochsner / Senior Director, IR &Corporate CommunicationsCorporate Communications Auxilium Pharmaceuticals, Inc.Auxilium Pharmaceuticals, Inc.  (484) 321-59(484) 321-5900kmattox@auxilium.comnochsner@auxilium.com


'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... KONG , July 28, 2014  Syneron Medical ... aesthetic device company, announced today that its new PicoWay® ... of all types and colors and pigmented lesions on ... dual wavelength device, with 532nm and 1064nm wavelengths, which ... the skin using pulses which are trillionths of a ...
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore ... dei disturbi respiratori del sonno (SDB) e altre patologie ... Germania contro il produttore Taiwanese di dispositivi medicali, APEX ... da indossare in testa, che violano i brevetti, utilizzate ... sentenza della Corte Regionale Distrettuale di Monaco ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, ... Roger Crystal , MD as Vice President of ... Global Business Development Product Acquisition & Licensing team at ... developing business strategy and partnerships in the precision medicine ... partner with biotechnology and pharmaceutical companies across the spectrum ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
...   Sigma-Aldrich ® Corporation (Nasdaq: SIAL ... Employers by the Corporate Research Foundation (CRF) Institute, ... associations, researchers and international publishers that offers independent ... one of nine companies that earned Top Employer ...
...  Nephros, Inc. (OTC Bulletin Board: NEPH ), ... for therapeutic applications, infection control, and water purification, announced ... year ended December 31, 2011. 2011 ... , Increased ultrafiltration product revenues  to approximately $618,000, ...
Cached Medicine Technology:CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 2CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 3Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 2Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 3Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 4Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 5Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 6Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 7Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 8
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... recipe app for iOS, App is available on iTunes for ... first of its kind, Audio Chef allows you to listen ... gourmet cuisine the easy way: simply get out the ingredients ... no need to measure or prepare ingredients ahead of time, ...
(Date:7/28/2014)... meal you,ve ordered at a restaurantor when something ... your brain. , These waves are called ... cellsboth excitatory and inhibitoryplaying together in an orchestrated ... waves have been associated with higher-level brain function, ... to schizophrenia, Alzheimer,s disease, autism, epilepsy and other ...
(Date:7/28/2014)... 28, 2014 UT Southwestern Medical Center cancer ... irreversibly interferes with the activity of a mutated ... , The molecule, SML-8-73-1 (SML), interferes with the ... homolog. The gene produces proteins called K-Ras that ... result in normal cells dividing uncontrollably and turning ...
(Date:7/28/2014)... 2014 The report, “Blowing Agents ... - Trends and Forecasts to 2019” defines and ... and forecasting of the global consumption volume and ... tables with 39 figures spread through 226 Pages ... http://www.marketsandmarkets.com/Market-Reports/blowing-agents-market-71329121.html , Blowing agents are highly utilized ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4
... debate is still on. Is Hormone Replacement Therapy (HRT), good ... caution. The treatment, which targets menopausal women by giving them ... two -edged sword. Its risks such as breast cancer, and ... traumatic menopausal symptoms. This was mainly due to a 2002 ...
... have criticized Prime Minister John Howard for calling for a ... there was no evidence to suggest migrants were responsible for ... Minister Howard had made the suggestion in an interview to ... sharp rise in HIV cases. ,Don Baxter, ...
... forces to perfect a powerful new weapon in the war ... spores. //Their results are published in the prestigious journal Science, ... to use lasers to detect anthrax in real time as ... now,” says Marlan Scully, Distinguished Professor of Physics at Texas ...
... sexually transmitted disease, has become so drug resistant now ... options to treat this serious disease. ,Doctors prescribe ... ofloxacin, and levofloxacin) as a treatment for the disease. ... and Prevention (CDC) says that the sexual disorder-that affects ...
... are now looking at lactate with a much more ... the brain in the immediate //hours after a traumatic ... they are right, it could change how emergency room ... injuries in the first critical hours after injury. ...
... Viagra, Cialis, and Levitra are the answer to their ... a new report from Harvard Medical School, these pills ... pressures that frequently accompany erectile dysfunction (ED). ... man is feeling sexual desire for his partner. If ...
Cached Medicine News:Health News:Hormone Replacement Therapy – To Choose Or No 2Health News:HIV Experts Criticize Australian PM's Suggestion for Ban on Entry of HIV-infected 2Health News:Physicists Unite To Develop Anthrax Detection Method 2Health News:Physicists Unite To Develop Anthrax Detection Method 3Health News:Physicists Unite To Develop Anthrax Detection Method 4Health News:Scientists Concerned About Gonorrhea’s Drug Resistanc 2Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: